New strategies for treatment of pulmonary fibrosis.
作者信息
Phan S H
机构信息
Department of Pathology, University of Michigan Medical School, Ann Arbor 48109-0602, USA.
出版信息
Thorax. 1995 Apr;50(4):415-21. doi: 10.1136/thx.50.4.415.
Abstract
摘要
相似文献
1
New strategies for treatment of pulmonary fibrosis.治疗肺纤维化的新策略。
Thorax. 1995 Apr;50(4):415-21. doi: 10.1136/thx.50.4.415.
2
Suppressive effect of antisense DNA of platelet-derived growth factor on murine pulmonary fibrosis with silica particles.
Chest. 1997 Jun;111(6 Suppl):105S. doi: 10.1378/chest.111.6_supplement.105s.
3
Pulmonary fibrosis of sarcoidosis. New approaches, old ideas.结节病的肺纤维化。新方法，旧观念。
Am J Respir Cell Mol Biol. 2003 Sep;29(3 Suppl):S37-41.
4
Anticytokine approaches in pulmonary fibrosis: bringing factors into focus.肺纤维化的抗细胞因子治疗方法：聚焦相关因子
Thorax. 1997 Mar;52(3):294-6. doi: 10.1136/thx.52.3.294.
5
Locally instilled tumor necrosis factor α antisense oligonucleotide contributes to inhibition of TH 2-driven pulmonary fibrosis via induced CD4+ CD25+ Foxp3+ regulatory T cells.局部注射肿瘤坏死因子 α 反义寡核苷酸通过诱导 CD4+CD25+Foxp3+调节性 T 细胞促进 TH2 驱动的肺纤维化抑制。
J Gene Med. 2013 Nov-Dec;15(11-12):441-52. doi: 10.1002/jgm.2750.
6
The cytokines of pulmonary fibrosis: Much learned, much more to learn.肺纤维化的细胞因子：已知甚多，未知更多。
Cytokine. 2015 Jul;74(1):88-100. doi: 10.1016/j.cyto.2014.11.008. Epub 2014 Dec 24.
7
Idiopathic pulmonary fibrosis: molecular mechanisms and possible therapeutic strategies.特发性肺纤维化：分子机制及可能的治疗策略
Arch Immunol Ther Exp (Warsz). 2000;48(6):539-45.
8
Immune Mechanisms in Pulmonary Fibrosis.肺纤维化中的免疫机制
Am J Respir Cell Mol Biol. 2016 Sep;55(3):309-22. doi: 10.1165/rcmb.2016-0121TR.
9
[Byssinosis and rare hypersensitivity pneumonias].
Internist (Berl). 1974 Aug;15(8):412-21.
10
[The role of cytokines in pulmonary fibrosis].
Nihon Ika Daigaku Zasshi. 1996 Oct;63(5):391-4. doi: 10.1272/jnms1923.63.391.
引用本文的文献
1
Lactate transport inhibition therapeutically reprograms fibroblast metabolism in experimental pulmonary fibrosis.乳酸转运抑制在实验性肺纤维化中对成纤维细胞代谢进行治疗性重编程。
bioRxiv. 2024 Apr 28:2024.04.25.591150. doi: 10.1101/2024.04.25.591150.
2
Oxidants/antioxidants in idiopathic pulmonary fibrosis.特发性肺纤维化中的氧化剂/抗氧化剂
Thorax. 1995 Sep;50 Suppl 1(Suppl 1):S53-8. doi: 10.1136/thx.50.suppl_1.s53.
本文引用的文献
1
Administration of prostaglandin E1 analog reduces rat hepatic and Ito cell collagen gene expression and collagen accumulation after bile duct ligation injury.
Hepatology. 1993 Apr;17(4):707-14. doi: 10.1002/hep.1840170427.
2
Antisense oligonucleotides to interleukin-4 regulate IgE and IgG2a production by spleen cells from Nippostrongylus brasiliensis-infected rats.针对白细胞介素-4的反义寡核苷酸调节巴西日圆线虫感染大鼠脾脏细胞的IgE和IgG2a产生。
Eur J Immunol. 1993 Mar;23(3):659-63. doi: 10.1002/eji.1830230313.
3
Lipocytes from fibrotic rat liver have an impaired feedback response to procollagen propeptides.
Am J Physiol. 1993 Jan;264(1 Pt 1):G157-62. doi: 10.1152/ajpgi.1993.264.1.G157.
4
Diversity of airway epithelial cell targets for in vivo recombinant adenovirus-mediated gene transfer.体内重组腺病毒介导的基因转移的气道上皮细胞靶标的多样性。
J Clin Invest. 1993 Jan;91(1):225-34. doi: 10.1172/JCI116175.
5
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death.小鼠中转化生长因子β1基因无效突变会导致过度炎症反应和早期死亡。
Proc Natl Acad Sci U S A. 1993 Jan 15;90(2):770-4. doi: 10.1073/pnas.90.2.770.
6
Tumor necrosis factor and the therapeutic potential of anti-tumor necrosis factor antibodies.肿瘤坏死因子及抗肿瘤坏死因子抗体的治疗潜力
Crit Care Med. 1993 Oct;21(10 Suppl):S436-40. doi: 10.1097/00003246-199310001-00004.
7
8
TNF-alpha in rheumatoid arthritis and prospects of anti-TNF therapy.类风湿关节炎中的肿瘤坏死因子-α及抗TNF治疗的前景
Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S173-5.
9
Interleukin-1 receptor antagonist.白细胞介素-1受体拮抗剂
Adv Immunol. 1993;54:167-227. doi: 10.1016/s0065-2776(08)60535-0.
10
New perspectives on basic mechanisms in lung disease. 6. Proteinase imbalance: its role in lung disease.肺部疾病基本机制的新观点。6. 蛋白酶失衡：其在肺部疾病中的作用。
Thorax. 1993 May;48(5):560-5. doi: 10.1136/thx.48.5.560.
Zotero 插件